SG11201609254YA - Therapeutic placental compositions, methods of making and methods of use - Google Patents

Therapeutic placental compositions, methods of making and methods of use

Info

Publication number
SG11201609254YA
SG11201609254YA SG11201609254YA SG11201609254YA SG11201609254YA SG 11201609254Y A SG11201609254Y A SG 11201609254YA SG 11201609254Y A SG11201609254Y A SG 11201609254YA SG 11201609254Y A SG11201609254Y A SG 11201609254YA SG 11201609254Y A SG11201609254Y A SG 11201609254YA
Authority
SG
Singapore
Prior art keywords
methods
making
placental compositions
therapeutic placental
therapeutic
Prior art date
Application number
SG11201609254YA
Inventor
Timothy Jansen
Samson Tom
Alla Danilkovitch
Dana Yoo
Jaime Zerhusen
Gabriele Putz Todd
Amy Elizabeth Johnson
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of SG11201609254YA publication Critical patent/SG11201609254YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG11201609254YA 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use SG11201609254YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037201 WO2015171142A1 (en) 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
SG11201609254YA true SG11201609254YA (en) 2016-12-29

Family

ID=54392804

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201609254YA SG11201609254YA (en) 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use

Country Status (7)

Country Link
EP (1) EP3139935A4 (en)
JP (1) JP2017514876A (en)
KR (1) KR20160147058A (en)
AU (1) AU2014393402A1 (en)
CA (1) CA2948126A1 (en)
SG (1) SG11201609254YA (en)
WO (1) WO2015171142A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207353B2 (en) 2010-02-18 2021-12-28 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7011135B2 (en) * 2016-02-19 2022-02-10 佳秀工業株式会社 A method for producing a vascular endothelial growth factor production promoter and a hair growth agent, and a vascular endothelial growth factor production promoter and a hair growth agent.
CN109069867B (en) * 2016-03-14 2022-02-01 无痛疗法股份有限公司 Cell-free placenta preparation
EP3432896A4 (en) * 2016-03-23 2020-01-15 MiMedx Group, Inc. Compositions and methods of treatment with amniotic fluid
WO2018039294A1 (en) 2016-08-24 2018-03-01 Arthrex, Inc. Tissue use for repair of injury
US10960028B2 (en) 2017-02-01 2021-03-30 Plakous Therapeutics, Inc. Placental tissue compositions
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
WO2021003257A1 (en) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Methods and compositions for collecting and using placental tissue cells and placental blood cells
WO2021101802A2 (en) * 2019-11-21 2021-05-27 Bioventus, Llc . Placental tissue particulate compositions and methods of use
WO2021123320A1 (en) * 2019-12-20 2021-06-24 Dr. Kalali Prof. Mostafazadeh Dipl. Ing. Miedl (Kmm) Gesellschaft Bürgerlichen Rechts A composition and its use for a universal therapy against tumor cells
KR102116954B1 (en) * 2019-12-26 2020-05-29 주식회사 엠케이바이오텍 Composition for cryopreservation and lyophilization of fetal stem cells
WO2022074523A1 (en) * 2020-10-06 2022-04-14 Osiris Therapeutics, Inc. Primed placental tissue and uses in regenerative medicine
WO2022183100A1 (en) * 2021-02-26 2022-09-01 Crown Scientific, L.L.C. Villi stromal cells compositions and uses thereof
WO2023192484A2 (en) * 2022-04-01 2023-10-05 Bright Cell, Inc. A mesenchymal stem cells formulation for cosmetic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058495A2 (en) * 2000-02-11 2001-08-16 The General Hospital Corporation Photochemical tissue bonding
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
WO2005001079A2 (en) * 2003-06-27 2005-01-06 Ethicon, Incorporated Soft tissue repair and regeneration using postpartum-derived cells
WO2009121002A1 (en) * 2008-03-27 2009-10-01 Biolife Solutions, Inc. Materials and methods for hypothermic collection of whole blood
ES2663720T3 (en) * 2010-02-18 2018-04-16 Osiris Therapeutics, Inc. Methods of manufacturing therapeutic products comprising vitalized placental dispersions
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US20140106447A1 (en) * 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207353B2 (en) 2010-02-18 2021-12-28 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products

Also Published As

Publication number Publication date
AU2014393402A1 (en) 2016-11-24
EP3139935A1 (en) 2017-03-15
EP3139935A4 (en) 2017-11-15
WO2015171142A1 (en) 2015-11-12
JP2017514876A (en) 2017-06-08
KR20160147058A (en) 2016-12-21
CA2948126A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
HK1254525A1 (en) Therapeutic compositions, combinations, and methods of use
IL286316A (en) Novel micro-dystrophins and related methods of use
IL272306B (en) Analogs of pridopidine, their preparation and use
IL277069B (en) Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
HK1258062A1 (en) Methods of administering elagolix
SG11201609254YA (en) Therapeutic placental compositions, methods of making and methods of use
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
HK1232137A1 (en) Therapeutic compounds and compositions
IL259246A (en) Compositions of therapeutic substances, methods and uses thereof
HK1259372A1 (en) Therapeutic compounds, compositions and methods of use thereof
SG11201708114SA (en) Ophthalmic compositions and methods of use therefor
IL285882A (en) Therapeutic uses of l-4-chlorokynurenine
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
HK1255221A1 (en) Methods of treatment using cadotril compositions
PL2998311T3 (en) Mixture of alkylglycosides, manufacture and use thereof
IL259710A (en) Compositions and methods of treatment for mvid and related diseases
HK1243404A1 (en) Tryptamide compositions and methods of use
HK1258765A1 (en) Therapeutic compounds, compositions and methods of use thereof
HK1259196A1 (en) Delayed-release formulations, methods of making and use thereof
GB201419559D0 (en) Therapeutic compositions and methods
EP3212202A4 (en) Use of therapeutic agents
GB201418272D0 (en) Composition & methods of treatment
GB201418268D0 (en) Composition & methods of treatment
AU2014904330A0 (en) Use of therapeutic agents